Compare AMRX & MHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRX | MHO |
|---|---|---|
| Founded | 2002 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.5B |
| IPO Year | N/A | 1986 |
| Metric | AMRX | MHO |
|---|---|---|
| Price | $13.34 | $126.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $13.25 | ★ $153.00 |
| AVG Volume (30 Days) | ★ 1.7M | 194.7K |
| Earning Date | 10-30-2025 | 01-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.02 | ★ 17.05 |
| Revenue | $2,934,959,000.00 | ★ $4,475,753,000.00 |
| Revenue This Year | $9.99 | N/A |
| Revenue Next Year | $6.67 | N/A |
| P/E Ratio | $807.28 | ★ $7.55 |
| Revenue Growth | ★ 9.50 | 4.77 |
| 52 Week Low | $6.69 | $100.22 |
| 52 Week High | $13.25 | $158.92 |
| Indicator | AMRX | MHO |
|---|---|---|
| Relative Strength Index (RSI) | 68.90 | 40.24 |
| Support Level | $12.33 | $125.20 |
| Resistance Level | $12.99 | $130.64 |
| Average True Range (ATR) | 0.30 | 3.15 |
| MACD | 0.00 | -0.29 |
| Stochastic Oscillator | 92.28 | 13.69 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
M/I Homes Inc is an American construction company that focuses on residential construction. It consists of two distinct operations: homebuilding and financial services. The homebuilding operations are spread into the Midwest, Mid-Atlantic, and Southern regions, and the financial services operations support homebuilding operations by providing mortgage loans and title services to the customers of homebuilding operations. Homebuilding operations comprise a predominant portion of the revenue. The company builds homes and communities that target entry-level, move-up, and luxury homebuyers.